Digitisation | January 14, 2022
Hekka Labs introduces decentralized chronic disease data management in South Asia
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
The last date to apply for this program is 18th January 2022
ICICI Direct gives a preview on the earnings narrative for Q3FY22
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
Subscribe To Our Newsletter & Stay Updated
